Search

Author/Creator Filliol, Aveline

1. A Therapeutic Silencing RNA Targeting Hepatocyte TAZ Prevents and Reverses Fibrosis in Nonalcoholic Steatohepatitis in Mice. Issue 9 (23rd July 2019)

Authors:
Wang, Xiaobo; Sommerfeld, Mark R.; Jahn‐Hofmann, Kerstin; Cai, Bishuang; Filliol, Aveline; Remotti, Helen E.; Schwabe, Robert F.; Kannt, Aimo; Tabas, Ira
Journal:
Hepatology communications
Issue:
Volume 3:Issue 9(2019)
Page Start:
1221
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Macrophage‐derived HMGB1 is dispensable for tissue fibrogenesis. Issue 4 (12th February 2019)

Authors:
Personnaz, Jean; Piccolo, Enzo; Branchereau, Maxime; Filliol, Aveline; Paccoud, Romain; Moreau, Elsa; Calise, Denis; Riant, Elodie; Gourdy, Pierre; Heymes, Christophe; Schwabe, Robert F.; Dray, Cédric; Valet, Philippe; Pradère, Jean‐Philippe
Journal:
FASEB bioAdvances
Issue:
Volume 1:Issue 4(2019)
Page Start:
227
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Sibiriline, a new small chemical inhibitor of receptor‐interacting protein kinase 1, prevents immune‐dependent hepatitis. (11th August 2017)

Authors:
Le Cann, Fabienne; Delehouzé, Claire; Leverrier‐Penna, Sabrina; Filliol, Aveline; Comte, Arnaud; Delalande, Olivier; Desban, Nathalie; Baratte, Blandine; Gallais, Isabelle; Piquet‐Pellorce, Claire; Faurez, Florence; Bonnet, Marion; Mettey, Yvette; Goekjian, Peter; Samson, Michel; Vandenabeele, Pe...
Journal:
FEBS journal
Issue:
Volume 284:Number 18(2017)
Page Start:
3050
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗